| inactivation of mapk activity | GO:0000188 | 2 | 1.000 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 13 | 0.999 | |
| conditioned taste aversion | GO:0001661 | 2 | 0.995 | |
| response to amphetamine | GO:0001975 | 25 | 0.994 | |
| regulation of nucleic acid templated transcription | GO:1903506 | 380 | 0.991 | |
| regulation of rna biosynthetic process | GO:2001141 | 381 | 0.989 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 33 | 0.987 | |
| regulation of rna metabolic process | GO:0051252 | 391 | 0.983 | |
| positive regulation of rna metabolic process | GO:0051254 | 203 | 0.981 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 252 | 0.979 | |
| regulation of transcription dna templated | GO:0006355 | 374 | 0.975 | |
| rna metabolic process | GO:0016070 | 406 | 0.970 | |
| cellular response to mycophenolic acid | GO:0071506 | 2 | 0.969 | |
| collateral sprouting | GO:0048668 | 2 | 0.955 | |
| rna biosynthetic process | GO:0032774 | 380 | 0.949 | |
| transcription dna templated | GO:0006351 | 377 | 0.948 | |
| nucleic acid templated transcription | GO:0097659 | 379 | 0.948 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 75 | 0.945 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 41 | 0.919 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 141 | 0.911 | |
| cell proliferation involved in kidney development | GO:0072111 | 5 | 0.907 | |
| cellular response to hormone stimulus | GO:0032870 | 247 | 0.903 | |
| skeletal muscle cell differentiation | GO:0035914 | 2 | 0.897 | |
| glomerular mesangial cell proliferation | GO:0072110 | 4 | 0.888 | |
| response to camp | GO:0051591 | 91 | 0.883 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 234 | 0.876 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 148 | 0.857 | |
| cytokine mediated signaling pathway | GO:0019221 | 43 | 0.857 | |
| negative regulation of rna metabolic process | GO:0051253 | 123 | 0.834 | |
| negative regulation of gene expression | GO:0010629 | 199 | 0.831 | |
| negative regulation of transcription dna templated | GO:0045892 | 116 | 0.825 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 117 | 0.824 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 161 | 0.824 | |
| response to hydrogen peroxide | GO:0042542 | 89 | 0.811 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 148 | 0.803 | |
| negative regulation of mapk cascade | GO:0043409 | 20 | 0.797 | |
| negative regulation of cellular metabolic process | GO:0031324 | 281 | 0.796 | |
| cell proliferation involved in metanephros development | GO:0072203 | 2 | 0.784 | |
| response to organophosphorus | GO:0046683 | 102 | 0.776 | |
| regulation of protein metabolic process | GO:0051246 | 289 | 0.765 | |
| regulation of metanephros development | GO:0072215 | 4 | 0.752 | |
| response to amine | GO:0014075 | 46 | 0.749 | |
| circulatory system development | GO:0072359 | 134 | 0.744 | |
| regulation of cellular protein metabolic process | GO:0032268 | 267 | 0.733 | |
| negative regulation of biosynthetic process | GO:0009890 | 168 | 0.731 | |
| long term synaptic potentiation | GO:0060291 | 21 | 0.730 | |
| response to heparin | GO:0071503 | 2 | 0.726 | |
| positive regulation of multicellular organismal process | GO:0051240 | 387 | 0.715 | |
| metanephric glomerular mesangium development | GO:0072223 | 1 | 0.701 | |
| negative regulation of multicellular organismal process | GO:0051241 | 203 | 0.699 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 334 | 0.690 | |
| negative regulation of macromolecule metabolic process | GO:0010605 | 260 | 0.669 | |
| positive regulation of g0 to g1 transition | GO:0070318 | 2 | 0.667 | |
| erk1 and erk2 cascade | GO:0070371 | 48 | 0.662 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 118 | 0.652 | |
| regulation of apoptotic process | GO:0042981 | 335 | 0.630 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 319 | 0.628 | |
| negative regulation of molecular function | GO:0044092 | 133 | 0.618 | |
| cellular response to interleukin 1 | GO:0071347 | 37 | 0.614 | |
| metanephric nephron development | GO:0072210 | 7 | 0.614 | |
| positive regulation of transcription dna templated | GO:0045893 | 197 | 0.607 | |
| response to interleukin 1 | GO:0070555 | 55 | 0.605 | |
| regulation of catalytic activity | GO:0050790 | 304 | 0.605 | |
| oligodendrocyte differentiation | GO:0048709 | 32 | 0.603 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 27 | 0.603 | |
| bmp signaling pathway | GO:0030509 | 4 | 0.603 | |
| tissue development | GO:0009888 | 252 | 0.586 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 247 | 0.585 | |
| cellular response to isoquinoline alkaloid | GO:0071317 | 6 | 0.584 | |
| positive regulation of mrna catabolic process | GO:0061014 | 2 | 0.583 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 197 | 0.579 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 153 | 0.577 | |
| programmed cell death | GO:0012501 | 392 | 0.575 | |
| positive regulation of biosynthetic process | GO:0009891 | 319 | 0.571 | |
| response to catecholamine | GO:0071869 | 16 | 0.564 | |
| interleukin 1 mediated signaling pathway | GO:0070498 | 2 | 0.547 | |
| response to purine containing compound | GO:0014074 | 126 | 0.546 | |
| cellular response to growth factor stimulus | GO:0071363 | 162 | 0.545 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 161 | 0.542 | |
| response to acid chemical | GO:0001101 | 222 | 0.529 | |
| positive regulation of gene expression | GO:0010628 | 244 | 0.526 | |
| response to oxidative stress | GO:0006979 | 186 | 0.517 | |
| negative regulation of cell death | GO:0060548 | 229 | 0.511 | |
| positive regulation of cell proliferation involved in kidney development | GO:1901724 | 4 | 0.507 | |
| immune system process | GO:0002376 | 204 | 0.507 | |
| response to peptide hormone | GO:0043434 | 278 | 0.500 | |
| neuron death | GO:0070997 | 127 | 0.488 | |
| apoptotic process | GO:0006915 | 381 | 0.487 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 17 | 0.483 | |
| regulation of g0 to g1 transition | GO:0070316 | 3 | 0.482 | |
| regulation of glomerulus development | GO:0090192 | 4 | 0.481 | |
| embryonic placenta development | GO:0001892 | 1 | 0.472 | |
| mrna 3 end processing | GO:0031124 | 1 | 0.471 | |
| glomerular mesangium development | GO:0072109 | 4 | 0.469 | |
| cellular response to lipid | GO:0071396 | 201 | 0.466 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 295 | 0.454 | |
| motor neuron axon guidance | GO:0008045 | 1 | 0.452 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 197 | 0.446 | |
| regulation of multicellular organismal development | GO:2000026 | 376 | 0.445 | |
| cellular response to acid chemical | GO:0071229 | 75 | 0.436 | |
| response to cold | GO:0009409 | 29 | 0.433 | |
| negative regulation of cell proliferation | GO:0008285 | 119 | 0.431 | |
| mapk cascade | GO:0000165 | 140 | 0.431 | |
| response to peptide | GO:1901652 | 292 | 0.429 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 4 | 0.427 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 106 | 0.424 | |
| regulation of osteoclast differentiation | GO:0045670 | 8 | 0.415 | |
| regulation of kidney development | GO:0090183 | 15 | 0.409 | |
| regulation of phosphate metabolic process | GO:0019220 | 349 | 0.402 | |
| positive regulation of glomerular metanephric mesangial cell proliferation | GO:0072303 | 1 | 0.394 | |
| regulation of cell proliferation involved in kidney development | GO:1901722 | 4 | 0.393 | |
| response to ketone | GO:1901654 | 182 | 0.390 | |
| protein phosphorylation | GO:0006468 | 345 | 0.388 | |
| regulation of nervous system development | GO:0051960 | 264 | 0.386 | |
| response to cytokine | GO:0034097 | 215 | 0.386 | |
| response to mycophenolic acid | GO:0071505 | 2 | 0.382 | |
| response to mechanical stimulus | GO:0009612 | 134 | 0.381 | |
| cellular response to cycloheximide | GO:0071409 | 4 | 0.379 | |
| negative regulation of metabolic process | GO:0009892 | 331 | 0.372 | |
| regulation of molecular function | GO:0065009 | 398 | 0.372 | |
| regulation of mrna 3 end processing | GO:0031440 | 1 | 0.371 | |
| metanephric glomerulus development | GO:0072224 | 3 | 0.371 | |
| signal transduction by phosphorylation | GO:0023014 | 144 | 0.367 | |
| chemotaxis | GO:0006935 | 66 | 0.356 | |
| regulation of transferase activity | GO:0051338 | 123 | 0.350 | |
| t cell differentiation | GO:0030217 | 9 | 0.350 | |
| cellular response to stress | GO:0033554 | 269 | 0.345 | |
| neurological system process | GO:0050877 | 219 | 0.342 | |
| regulation of kinase activity | GO:0043549 | 117 | 0.340 | |
| regulation of protein modification process | GO:0031399 | 194 | 0.338 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 45 | 0.336 | |
| dephosphorylation | GO:0016311 | 98 | 0.333 | |
| response to light stimulus | GO:0009416 | 52 | 0.333 | |
| positive regulation of apoptotic process | GO:0043065 | 154 | 0.332 | |
| response to mineralocorticoid | GO:0051385 | 49 | 0.321 | |
| rhythmic process | GO:0048511 | 156 | 0.321 | |
| response to molecule of bacterial origin | GO:0002237 | 194 | 0.321 | |
| cellular response to endogenous stimulus | GO:0071495 | 377 | 0.317 | |
| cellular response to insulin stimulus | GO:0032869 | 81 | 0.315 | |
| embryonic cranial skeleton morphogenesis | GO:0048701 | 2 | 0.313 | |
| positive regulation of programmed cell death | GO:0043068 | 157 | 0.303 | |
| cellular response to cytokine stimulus | GO:0071345 | 127 | 0.302 | |
| cellular response to camp | GO:0071320 | 26 | 0.301 | |
| response to other organism | GO:0051707 | 220 | 0.299 | |
| regulation of neuron apoptotic process | GO:0043523 | 83 | 0.299 | |
| reproductive process | GO:0022414 | 372 | 0.296 | |
| neuron apoptotic process | GO:0051402 | 88 | 0.293 | |
| response to bacterium | GO:0009617 | 200 | 0.293 | |
| negative regulation of oligodendrocyte differentiation | GO:0048715 | 3 | 0.291 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 120 | 0.288 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 3 | 0.287 | |
| eye development | GO:0001654 | 50 | 0.285 | |
| response to isoquinoline alkaloid | GO:0014072 | 28 | 0.282 | |
| positive regulation of signaling | GO:0023056 | 270 | 0.282 | |
| negative regulation of programmed cell death | GO:0043069 | 183 | 0.281 | |
| immune system development | GO:0002520 | 41 | 0.277 | |
| synaptic growth at neuromuscular junction | GO:0051124 | 1 | 0.276 | |
| response to glucocorticoid | GO:0051384 | 223 | 0.272 | |
| anatomical structure morphogenesis | GO:0009653 | 298 | 0.272 | |
| neuron development | GO:0048666 | 286 | 0.269 | |
| regulation of programmed cell death | GO:0043067 | 341 | 0.267 | |
| behavior | GO:0007610 | 205 | 0.264 | |
| taxis | GO:0042330 | 67 | 0.264 | |
| response to growth factor | GO:0070848 | 189 | 0.261 | |
| regulation of protein kinase activity | GO:0045859 | 105 | 0.258 | |
| negative regulation of apoptotic process | GO:0043066 | 181 | 0.257 | |
| regulation of cell proliferation | GO:0042127 | 359 | 0.255 | |
| circadian rhythm | GO:0007623 | 88 | 0.254 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 1 | 0.251 | |
| neuron differentiation | GO:0030182 | 368 | 0.250 | |
| regulation of signal transduction | GO:0009966 | 318 | 0.249 | |
| positive regulation of cellular catabolic process | GO:0031331 | 71 | 0.249 | |
| response to alkaloid | GO:0043279 | 132 | 0.241 | |
| response to follicle stimulating hormone | GO:0032354 | 18 | 0.240 | |
| response to extracellular stimulus | GO:0009991 | 380 | 0.238 | |
| positive regulation of cell death | GO:0010942 | 184 | 0.237 | |
| myeloid leukocyte differentiation | GO:0002573 | 20 | 0.236 | |
| response to corticosterone | GO:0051412 | 40 | 0.234 | |
| positive regulation of metanephros development | GO:0072216 | 2 | 0.233 | |
| response to inorganic substance | GO:0010035 | 377 | 0.229 | |
| positive regulation of catalytic activity | GO:0043085 | 184 | 0.228 | |
| nucleobase containing compound catabolic process | GO:0034655 | 152 | 0.227 | |
| blood vessel development | GO:0001568 | 69 | 0.224 | |
| negative regulation of nervous system development | GO:0051961 | 79 | 0.223 | |
| response to radiation | GO:0009314 | 137 | 0.221 | |
| cellular component morphogenesis | GO:0032989 | 155 | 0.216 | |
| t cell activation | GO:0042110 | 29 | 0.215 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 116 | 0.215 | |
| response to gamma radiation | GO:0010332 | 24 | 0.207 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 64 | 0.206 | |
| negative regulation of angiogenesis | GO:0016525 | 10 | 0.205 | |
| response to calcium ion | GO:0051592 | 59 | 0.203 | |
| cellular response to alkaloid | GO:0071312 | 25 | 0.202 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 11 | 0.202 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 7 | 0.200 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 1 | 0.200 | |
| response to nutrient levels | GO:0031667 | 370 | 0.200 | |
| negative regulation of protein metabolic process | GO:0051248 | 114 | 0.199 | |
| nephron development | GO:0072006 | 22 | 0.197 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 80 | 0.197 | |
| regulation of protein phosphorylation | GO:0001932 | 183 | 0.197 | |
| response to ethanol | GO:0045471 | 162 | 0.195 | |
| axonogenesis | GO:0007409 | 71 | 0.194 | |
| metanephric glomerulus vasculature development | GO:0072239 | 1 | 0.191 | |
| response to toxic substance | GO:0009636 | 133 | 0.189 | |
| preganglionic parasympathetic nervous system development | GO:0021783 | 1 | 0.189 | |
| circadian behavior | GO:0048512 | 24 | 0.185 | |
| rhombomere morphogenesis | GO:0021593 | 1 | 0.184 | |
| regulation of phosphorylation | GO:0042325 | 248 | 0.182 | |
| cellular response to oxygen containing compound | GO:1901701 | 386 | 0.179 | |
| cell type specific apoptotic process | GO:0097285 | 134 | 0.178 | |
| cell projection organization | GO:0030030 | 302 | 0.173 | |
| neuron projection development | GO:0031175 | 273 | 0.172 | |
| learning or memory | GO:0007611 | 90 | 0.170 | |
| response to reactive oxygen species | GO:0000302 | 120 | 0.168 | |
| cellular response to vascular endothelial growth factor stimulus | GO:0035924 | 6 | 0.166 | |
| positive regulation of glomerular mesangial cell proliferation | GO:0072126 | 4 | 0.164 | |
| positive regulation of mrna metabolic process | GO:1903313 | 4 | 0.164 | |
| regulation of natural killer cell mediated immune response to tumor cell | GO:0002855 | 1 | 0.163 | |
| aging | GO:0007568 | 241 | 0.160 | |
| response to wounding | GO:0009611 | 254 | 0.157 | |
| growth | GO:0040007 | 165 | 0.153 | |
| regulation of phosphorus metabolic process | GO:0051174 | 349 | 0.152 | |
| single organism reproductive process | GO:0044702 | 297 | 0.152 | |
| regulation of intracellular signal transduction | GO:1902531 | 218 | 0.149 | |
| wound healing | GO:0042060 | 122 | 0.146 | |
| response to cycloheximide | GO:0046898 | 6 | 0.146 | |
| intracellular signal transduction | GO:0035556 | 314 | 0.145 | |
| regulation of gene expression epigenetic | GO:0040029 | 10 | 0.144 | |
| central nervous system development | GO:0007417 | 311 | 0.137 | |
| carbon catabolite activation of transcription | GO:0045991 | 1 | 0.137 | |
| carbohydrate derivative metabolic process | GO:1901135 | 346 | 0.136 | |
| cellular response to organic cyclic compound | GO:0071407 | 202 | 0.136 | |
| response to insulin | GO:0032868 | 133 | 0.135 | |
| rhythmic behavior | GO:0007622 | 24 | 0.134 | |
| glial cell differentiation | GO:0010001 | 65 | 0.134 | |
| connective tissue development | GO:0061448 | 33 | 0.133 | |
| protein dephosphorylation | GO:0006470 | 38 | 0.132 | |
| cellular response to drug | GO:0035690 | 30 | 0.130 | |
| mrna stabilization | GO:0048255 | 2 | 0.129 | |
| positive regulation of developmental process | GO:0051094 | 283 | 0.128 | |
| response to biotic stimulus | GO:0009607 | 226 | 0.126 | |
| negative regulation of signal transduction | GO:0009968 | 83 | 0.126 | |
| response to estradiol | GO:0032355 | 164 | 0.126 | |
| positive regulation of glomerulus development | GO:0090193 | 4 | 0.125 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 106 | 0.125 | |
| response to decreased oxygen levels | GO:0036293 | 237 | 0.124 | |
| cellular response to organonitrogen compound | GO:0071417 | 197 | 0.123 | |
| kidney vasculature development | GO:0061440 | 6 | 0.117 | |
| neuron projection regeneration | GO:0031102 | 35 | 0.116 | |
| regulation of neuron death | GO:1901214 | 115 | 0.114 | |
| regulation of cell development | GO:0060284 | 263 | 0.112 | |
| negative regulation of response to stimulus | GO:0048585 | 155 | 0.111 | |
| response to carbon monoxide | GO:0034465 | 4 | 0.110 | |
| response to external biotic stimulus | GO:0043207 | 221 | 0.110 | |
| positive regulation of cell differentiation | GO:0045597 | 217 | 0.109 | |
| multi multicellular organism process | GO:0044706 | 138 | 0.108 | |
| positive regulation of cell proliferation | GO:0008284 | 249 | 0.108 | |
| secretion | GO:0046903 | 307 | 0.104 | |
| response to ammonium ion | GO:0060359 | 71 | 0.103 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 41 | 0.103 | |
| cell morphogenesis | GO:0000902 | 142 | 0.102 | |
| positive regulation of cell communication | GO:0010647 | 271 | 0.101 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 80 | 0.096 | |
| vesicle mediated transport | GO:0016192 | 181 | 0.095 | |
| positive regulation of nervous system development | GO:0051962 | 178 | 0.095 | |
| facial nerve development | GO:0021561 | 1 | 0.092 | |
| viral transcription | GO:0019083 | 2 | 0.091 | |
| glomerulus development | GO:0032835 | 10 | 0.090 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 93 | 0.090 | |
| response to cocaine | GO:0042220 | 39 | 0.090 | |
| regulation of catabolic process | GO:0009894 | 113 | 0.089 | |
| sensory organ development | GO:0007423 | 74 | 0.089 | |
| axon development | GO:0061564 | 96 | 0.088 | |
| d amino acid transport | GO:0042940 | 1 | 0.087 | |
| negative regulation of erk1 and erk2 cascade | GO:0070373 | 9 | 0.087 | |
| protein localization | GO:0008104 | 191 | 0.087 | |
| regulation of neurogenesis | GO:0050767 | 247 | 0.085 | |
| response to estrogen | GO:0043627 | 232 | 0.085 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 163 | 0.084 | |
| multi organism reproductive process | GO:0044703 | 262 | 0.082 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 4 | 0.082 | |
| cell part morphogenesis | GO:0032990 | 123 | 0.082 | |
| protein sumoylation | GO:0016925 | 4 | 0.080 | |
| cell projection morphogenesis | GO:0048858 | 123 | 0.078 | |
| response to lipopolysaccharide | GO:0032496 | 191 | 0.077 | |
| locomotor rhythm | GO:0045475 | 1 | 0.076 | |
| positive regulation of immune system process | GO:0002684 | 90 | 0.076 | |
| rhombomere development | GO:0021546 | 1 | 0.076 | |
| cognition | GO:0050890 | 92 | 0.075 | |
| developmental growth | GO:0048589 | 100 | 0.074 | |
| regulation of response to external stimulus | GO:0032101 | 106 | 0.073 | |
| regulation of viral transcription | GO:0046782 | 2 | 0.073 | |
| axon regeneration | GO:0031103 | 28 | 0.073 | |
| gliogenesis | GO:0042063 | 93 | 0.073 | |
| protein transport | GO:0015031 | 132 | 0.072 | |
| multicellular organism reproduction | GO:0032504 | 233 | 0.071 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 36 | 0.071 | |
| negative regulation of cell differentiation | GO:0045596 | 99 | 0.071 | |
| striated muscle tissue development | GO:0014706 | 58 | 0.070 | |
| leukocyte activation | GO:0045321 | 76 | 0.070 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 4 | 0.070 | |
| vasculature development | GO:0001944 | 70 | 0.070 | |
| cellular component assembly | GO:0022607 | 360 | 0.070 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 18 | 0.069 | |
| muscle tissue development | GO:0060537 | 58 | 0.069 | |
| regulation of cell differentiation | GO:0045595 | 320 | 0.066 | |
| response to electrical stimulus | GO:0051602 | 56 | 0.066 | |
| mitotic cell cycle | GO:0000278 | 49 | 0.066 | |
| positive regulation of neuron death | GO:1901216 | 43 | 0.065 | |
| neuron projection morphogenesis | GO:0048812 | 122 | 0.064 | |
| response to corticosteroid | GO:0031960 | 235 | 0.063 | |
| regulation of mapk cascade | GO:0043408 | 116 | 0.063 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 122 | 0.063 | |
| regulation of vasculature development | GO:1901342 | 44 | 0.063 | |
| negative regulation of developmental process | GO:0051093 | 125 | 0.063 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 7 | 0.062 | |
| learning | GO:0007612 | 33 | 0.062 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 83 | 0.061 | |
| response to metal ion | GO:0010038 | 253 | 0.061 | |
| regulation of interleukin 6 production | GO:0032675 | 12 | 0.061 | |
| cell cycle g2 m phase transition | GO:0044839 | 6 | 0.061 | |
| cellular response to peptide | GO:1901653 | 133 | 0.060 | |
| negative regulation of neuron death | GO:1901215 | 69 | 0.060 | |
| cellular component biogenesis | GO:0044085 | 368 | 0.059 | |
| skeletal muscle organ development | GO:0060538 | 33 | 0.059 | |
| regulation of map kinase activity | GO:0043405 | 53 | 0.059 | |
| chondroblast differentiation | GO:0060591 | 1 | 0.058 | |
| response to oxygen levels | GO:0070482 | 265 | 0.058 | |
| regulation of rna stability | GO:0043487 | 3 | 0.058 | |
| regulation of immune system process | GO:0002682 | 123 | 0.058 | |
| regulation of system process | GO:0044057 | 208 | 0.058 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 262 | 0.057 | |
| negative regulation of transferase activity | GO:0051348 | 29 | 0.057 | |
| positive regulation of synaptic transmission | GO:0050806 | 62 | 0.057 | |
| response to temperature stimulus | GO:0009266 | 94 | 0.056 | |
| response to retinoic acid | GO:0032526 | 63 | 0.056 | |
| regulation of myeloid cell differentiation | GO:0045637 | 12 | 0.056 | |
| organic substance catabolic process | GO:1901575 | 316 | 0.055 | |
| organic acid metabolic process | GO:0006082 | 292 | 0.055 | |
| leukocyte differentiation | GO:0002521 | 30 | 0.055 | |
| response to glucose | GO:0009749 | 136 | 0.054 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 12 | 0.054 | |
| multicellular organismal reproductive process | GO:0048609 | 233 | 0.054 | |
| response to muramyl dipeptide | GO:0032495 | 1 | 0.053 | |
| endocytosis | GO:0006897 | 84 | 0.053 | |
| regulation of dna methylation | GO:0044030 | 6 | 0.053 | |
| cellular macromolecule catabolic process | GO:0044265 | 29 | 0.052 | |
| muscle structure development | GO:0061061 | 87 | 0.052 | |
| sleep | GO:0030431 | 30 | 0.051 | |
| single organism behavior | GO:0044708 | 130 | 0.051 | |
| negative regulation of cell communication | GO:0010648 | 158 | 0.051 | |
| phagocytosis | GO:0006909 | 17 | 0.051 | |
| metanephros development | GO:0001656 | 14 | 0.050 | |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 14 | 0.050 | |
| heart process | GO:0003015 | 57 | 0.050 | |
| positive regulation of neurogenesis | GO:0050769 | 165 | 0.050 | |
| response to peptidoglycan | GO:0032494 | 1 | 0.049 | |
| photoperiodism | GO:0009648 | 4 | 0.049 | |
| rna catabolic process | GO:0006401 | 3 | 0.049 | |
| renal system development | GO:0072001 | 67 | 0.048 | |
| cellular ketone metabolic process | GO:0042180 | 51 | 0.048 | |
| embryo development | GO:0009790 | 49 | 0.047 | |
| skeletal muscle tissue development | GO:0007519 | 31 | 0.047 | |
| negative regulation of cell migration involved in sprouting angiogenesis | GO:0090051 | 1 | 0.047 | |
| tube development | GO:0035295 | 89 | 0.047 | |
| regulation of cellular catabolic process | GO:0031329 | 101 | 0.047 | |
| sexual reproduction | GO:0019953 | 148 | 0.045 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 17 | 0.045 | |
| organ regeneration | GO:0031100 | 101 | 0.045 | |
| negative regulation of protein kinase activity | GO:0006469 | 23 | 0.045 | |
| lymphocyte activation | GO:0046649 | 43 | 0.045 | |
| purine nucleotide metabolic process | GO:0006163 | 229 | 0.045 | |
| negative regulation of protein modification process | GO:0031400 | 52 | 0.044 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 11 | 0.044 | |
| purine nucleotide catabolic process | GO:0006195 | 136 | 0.043 | |
| glycosyl compound metabolic process | GO:1901657 | 182 | 0.043 | |
| response to gonadotropin | GO:0034698 | 34 | 0.042 | |
| nucleoside phosphate metabolic process | GO:0006753 | 283 | 0.042 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 4 | 0.042 | |
| establishment of protein localization | GO:0045184 | 141 | 0.041 | |
| feeding behavior | GO:0007631 | 53 | 0.041 | |
| positive regulation of response to external stimulus | GO:0032103 | 51 | 0.041 | |
| hair cell differentiation | GO:0035315 | 2 | 0.041 | |
| purine ribonucleotide catabolic process | GO:0009154 | 136 | 0.041 | |
| response to increased oxygen levels | GO:0036296 | 45 | 0.041 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 13 | 0.041 | |
| positive regulation of cell development | GO:0010720 | 176 | 0.041 | |
| associative learning | GO:0008306 | 19 | 0.041 | |
| tumor necrosis factor production | GO:0032640 | 13 | 0.041 | |
| response to testosterone | GO:0033574 | 55 | 0.041 | |
| positive regulation of mrna processing | GO:0050685 | 2 | 0.040 | |
| regulation of synaptic transmission | GO:0050804 | 141 | 0.040 | |
| positive regulation of catabolic process | GO:0009896 | 78 | 0.040 | |
| nucleoside metabolic process | GO:0009116 | 179 | 0.039 | |
| response to transforming growth factor beta | GO:0071559 | 46 | 0.039 | |
| regulation of bmp signaling pathway | GO:0030510 | 2 | 0.039 | |
| positive regulation of protein metabolic process | GO:0051247 | 178 | 0.039 | |
| positive regulation of cellular component organization | GO:0051130 | 200 | 0.039 | |
| cellular response to mechanical stimulus | GO:0071260 | 48 | 0.038 | |
| reproduction | GO:0000003 | 245 | 0.038 | |
| negative regulation of signaling | GO:0023057 | 157 | 0.038 | |
| transforming growth factor beta3 production | GO:0032907 | 2 | 0.038 | |
| circadian regulation of gene expression | GO:0032922 | 3 | 0.038 | |
| single organism biosynthetic process | GO:0044711 | 342 | 0.037 | |
| kidney development | GO:0001822 | 67 | 0.037 | |
| regulation of cytokine production | GO:0001817 | 56 | 0.036 | |
| cellular response to topologically incorrect protein | GO:0035967 | 3 | 0.036 | |
| organ senescence | GO:0010260 | 2 | 0.036 | |
| synaptic transmission | GO:0007268 | 235 | 0.036 | |
| cellular catabolic process | GO:0044248 | 295 | 0.036 | |
| negative regulation of phosphorylation | GO:0042326 | 57 | 0.036 | |
| jak stat cascade | GO:0007259 | 26 | 0.036 | |
| positive regulation of cellular protein metabolic process | GO:0032270 | 167 | 0.036 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 38 | 0.035 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 31 | 0.035 | |
| response to norepinephrine | GO:0071873 | 5 | 0.035 | |
| hemopoiesis | GO:0030097 | 34 | 0.035 | |
| response to axon injury | GO:0048678 | 59 | 0.035 | |
| gtp catabolic process | GO:0006184 | 71 | 0.034 | |
| parasympathetic nervous system development | GO:0048486 | 1 | 0.034 | |
| regulation of heart contraction | GO:0008016 | 48 | 0.033 | |
| negative regulation of neurogenesis | GO:0050768 | 78 | 0.033 | |
| positive regulation of response to stimulus | GO:0048584 | 285 | 0.033 | |
| dna metabolic process | GO:0006259 | 96 | 0.033 | |
| negative regulation of peptidase activity | GO:0010466 | 38 | 0.033 | |
| single organism carbohydrate metabolic process | GO:0044723 | 118 | 0.033 | |
| positive regulation of hydrolase activity | GO:0051345 | 86 | 0.032 | |
| epiboly involved in wound healing | GO:0090505 | 2 | 0.032 | |
| cellular response to abiotic stimulus | GO:0071214 | 85 | 0.031 | |
| placenta development | GO:0001890 | 22 | 0.030 | |
| muscle cell proliferation | GO:0033002 | 84 | 0.030 | |
| localization of cell | GO:0051674 | 202 | 0.030 | |
| response to morphine | GO:0043278 | 27 | 0.030 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 13 | 0.030 | |
| macromolecule localization | GO:0033036 | 252 | 0.030 | |
| cellular response to biotic stimulus | GO:0071216 | 59 | 0.029 | |
| urogenital system development | GO:0001655 | 78 | 0.029 | |
| developmental process involved in reproduction | GO:0003006 | 159 | 0.029 | |
| gamete generation | GO:0007276 | 124 | 0.029 | |
| negative regulation of cytokine production | GO:0001818 | 16 | 0.029 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 316 | 0.028 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 4 | 0.028 | |
| cytokine biosynthetic process | GO:0042089 | 3 | 0.028 | |
| entrainment of circadian clock | GO:0009649 | 3 | 0.028 | |
| small gtpase mediated signal transduction | GO:0007264 | 36 | 0.028 | |
| regulation of cell adhesion | GO:0030155 | 52 | 0.028 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 18 | 0.028 | |
| heterocycle catabolic process | GO:0046700 | 167 | 0.027 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 13 | 0.027 | |
| negative regulation of protein transport | GO:0051224 | 17 | 0.027 | |
| response to carbohydrate | GO:0009743 | 183 | 0.027 | |
| cytoplasmic transport | GO:0016482 | 115 | 0.027 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.027 | |
| positive regulation of protein phosphorylation | GO:0001934 | 135 | 0.027 | |
| regulation of protein processing | GO:0070613 | 50 | 0.027 | |
| positive regulation of chemotaxis | GO:0050921 | 23 | 0.027 | |
| ras protein signal transduction | GO:0007265 | 29 | 0.027 | |
| cell cell signaling | GO:0007267 | 335 | 0.026 | |
| interleukin 6 production | GO:0032635 | 12 | 0.026 | |
| carbohydrate biosynthetic process | GO:0016051 | 42 | 0.026 | |
| circulatory system process | GO:0003013 | 183 | 0.026 | |
| response to monoamine | GO:0071867 | 17 | 0.026 | |
| regulation of telomerase activity | GO:0051972 | 2 | 0.026 | |
| regeneration | GO:0031099 | 163 | 0.025 | |
| cardiovascular system development | GO:0072358 | 134 | 0.025 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 262 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 174 | 0.025 | |
| proteolysis | GO:0006508 | 175 | 0.025 | |
| p38mapk cascade | GO:0038066 | 1 | 0.024 | |
| mrna processing | GO:0006397 | 14 | 0.024 | |
| regulation of long term neuronal synaptic plasticity | GO:0048169 | 15 | 0.024 | |
| regulation of dna metabolic process | GO:0051052 | 60 | 0.024 | |
| epithelial cell differentiation | GO:0030855 | 71 | 0.024 | |
| regulation of peptidase activity | GO:0052547 | 55 | 0.024 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 31 | 0.024 | |
| cellular response to external stimulus | GO:0071496 | 118 | 0.024 | |
| cellular response to tumor necrosis factor | GO:0071356 | 46 | 0.024 | |
| negative regulation of catalytic activity | GO:0043086 | 103 | 0.023 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 7 | 0.023 | |
| positive regulation of ras gtpase activity | GO:0032320 | 28 | 0.023 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 119 | 0.023 | |
| negative regulation of muscle hyperplasia | GO:0014740 | 1 | 0.023 | |
| response to monosaccharide | GO:0034284 | 159 | 0.023 | |
| regulation of mrna stability | GO:0043488 | 3 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 227 | 0.022 | |
| rna stabilization | GO:0043489 | 2 | 0.022 | |
| regulation of gliogenesis | GO:0014013 | 39 | 0.022 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001269 | 1 | 0.022 | |
| regulation of ossification | GO:0030278 | 32 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 37 | 0.022 | |
| response to fibroblast growth factor | GO:0071774 | 29 | 0.022 | |
| apoptotic mitochondrial changes | GO:0008637 | 10 | 0.022 | |
| positive regulation of behavior | GO:0048520 | 38 | 0.022 | |
| cytoskeleton organization | GO:0007010 | 111 | 0.022 | |
